4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Mycophenolic acid/AG-CN2-0419-M100/100 mg
商品详细Adipogen/Mycophenolic acid/AG-CN2-0419-M100/100 mg
Adipogen/Mycophenolic acid/AG-CN2-0419-M100/100 mg
Adipogen/Mycophenolic acid/AG-CN2-0419-M100/100 mg
商品编号: AG-CN2-0419-M100
品牌: Adipogen Inc
市场价: ¥1300.00
美元价: 780.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsMPA;NSC129185;Ly68618;Mycophenolate
ProductTypeChemical
Properties
FormulaC17H20O6
MW320.3
MerckIndex14:6327
CAS24280-93-1
RTECSMP8050000
Source/HostChemicalsIsolatedfromPenicilliumbrevi-compactum.
PurityChemicals≥98%(HPLC,TLC)
AppearanceWhitetooff-whitesolid.
SolubilitySolubleinDMSO,methanolorethanol.Insolubleinwater.
InChiKeyHPNSFSBZBAHARI-RUDMXATFSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+20°C
LongTermStorage+4°C
HandlingAdviceKeepcoolanddry.
Use/StABIlityStableforatleast2yearsafterreceiptwhenstoredat+4°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Antibiotic[1].
  • Showsantiviral,antifungalandantitumorproperties[1,2].
  • Immunosuppressivedrugusedtopreventrejectioninorgantransplantation,rheumatoidarthritis,andpsoriasis[3-6,13].
  • PotentreversIBLeinhibitorofinosine-5"-monophosphatedehydrogenase(IMPDH),leADIngtodepletionofGMPandinterruptionofthedenovosynthesisofpurinenucleotidesnecessaryforBandTlymphocyteproliferation[7,8].
  • InhibitsthetypeIIIMPDHisoform(IMPDH-2)5-foldmorepotentlycomparedtotypeIisoform[11].
  • InhibitsRNAandDNAsynthesis[13].
  • Induciblenitricoxidesynthase(iNOS/NOSII)inhibitor[8,10].
  • Apoptosisandnecrosisinducer[9,12].
  • NoveltypeofinhibitoragainstRNAguanylyltransferases[14].
  • InhibitsTNF-α-stimulatedMAPK/NF-κBandROSgeneration[15].
  • Autophagysuppressor.
ProductReferences
  1. Mycophenolicacid:antiviralandantitumorproperties:R.H.Williams,etal.;J.Antibiot.21,463(1968)
  2. Mycophenolicacid:ananti-cancercompoundwithunusualproperties: S.B.Carter,etal.;Nature223,848(1969)
  3. Treatmentofpsoriasiswithoralmycophenolicacid:E.L.Jones,etal.;J.Invest.Dermatol.65,537(1975)
  4. Lymphocyte-selectivecytostaticandimmunosuppressiveeffectsofmycophenolicacidinvitro:roleofdeoxyguanosinenucleotidedepeletion:E.M.Eugui,etal.;Scand.J.Immunol.33,161(1991)
  5. Newsmallmoleculeimmunosuppressantsfortransplantation:reviewofessentialconcepts:R.E.Morris;J.HeartLungTransplant.12,275(1993)
  6. ImmunosuppressiveandotherEffectsofMycophenolicAcidandanEsterProdrug,MycophenolateMofetil:A.C.Allison&E.M.Eugui;Immunol.Rev.136,5(1993)
  7. Mechanismsofactionofmycophenolicacid:A.C.Allison,etal.;Ann.N.Y.Acad.Sci.696,63(1993)(Review)
  8. Mycophenolicacid,aninhibitorofIMPdehydrogenasethatisalsoanimmunosuppressiveagent,suppressesthecytokine-inducednitricoxideproductioninmouseandratvascularendothelialcells:M.Senda,etal.;Transplantation60,1143(1995)
  9. Mycophenolicacidincreasesapoptosis,lysosomesandlipiddropletsinhumanlymphoidandmonocyticcelllines:R.G.Cohn,etal.;Transplantation68,411(1999)
  10. Induciblenitricoxidesynthaseinhibitionbymycophenolicacid:D.J.Miljkovic,etal.;MiniRev.Med.Chem.4,741(2004)
  11. Mechanismsofactionofmycophenolatemofetilinpreventingacuteandchronicallograftrejection:A.C.Allison&E.M.Eugui;Transplantation80,S181(2005)
  12. Theimmunosuppressormycophenolicacidkillsactivatedlymphocytesbyinducinganonclassicalactin-dependentnecroticsignal:B.Chaigne-Delalande,etal.;J.Immunol.181,7630(2008)
  13. Mycophenolicacidinrheumatology:mechanismsofactionandsevereadverseevents:G.Zizzo,etal.;Reumatismo62,91(2010)(Review)
  14. Virtualhigh-throughputscreeningidentifiesmycophenolicacidasanovelRNAcappinginhibitor:M.Tremblay-Letourneau,etal.;PLoSOne6,e24806(2011)
  15. Mycophenolicacidattenuatesthetumournecrosisfactorα-mediatedproinflammatoryresponseinendothelialcellsbyblockingtheMAPK/NF-κBandROSpathways:W.Olejarz,etal.;Eur.J.Clin.Invest. 44, 54 (2014)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。